Pill shows benefit in certain hard-to-treat breast cancers

Breast cancer pill shows benefit in certain hard-to-treat cases

A pill has been shown to help keep certain early-stage, hard-to-treat breast cancers at bay after initial treatment in findings being reported early because they are so promising.

This Breast Cancer Pill Cuts Recurrence, Death Risks By 42%

AstraZeneca's pill, called Lynparza, has been found to reduce the recurrence of breast cancer in women who have been diagnosed with the disease at its early stages. In a long-running international study published by the New England Journal of Medicine, findings showed that Lynparza significantly lowered the risk of relapse and death among breast cancer patients by 42%. The positive results of the study offer hope that the drug could be used as a…

Study: Lynparza shows benefit in certain hard-to-treat breast cancers

A study found Lynparza helped breast cancer patients with harmful mutations live longer without disease after standard cancer treatments.

Scientists hails 'major breakthrough' in breast cancer treatment

Giving women the drug following chemotherapy significantly reduces the risk of inherited breast cancer returning or spreading, early results show.

Study: Lynparza shows benefit in certain hard-to-treat breast cancers

A study found Lynparza helped breast cancer patients with harmful mutations live longer without disease after standard cancer treatments.

Study: Lynparza shows benefit in certain hard-to-treat breast cancers

A study found Lynparza helped breast cancer patients with harmful mutations live longer without disease after standard cancer treatments.